Evidence map›Paper›PMID 25785065›Full record

ArticleInternational journal of clinical and experimental medicine2015

Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients.

Yingmin Lu, Shuxin Hou, Damin Huang, Xiaohan Luo, Jinchun Zhang, Jian Chen, Weiping Xu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. International journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Targeting Autophagy in Atrial Fibrillation.Reviews in cardiovascular medicine · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yingmin LuDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Shuxin HouDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Damin HuangDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Xiaohan LuoDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Jinchun ZhangDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Jian ChenDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
Weiping XuDepartment of Cardiology, Xinhua (Chongming) Hospital, School of Medicine, Shanghai Jiaotong University Shanghai 202150, China.
XinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the changes in expression profile of circulating microRNAs (miRNAs) and the regulatory effect of atrial fibrilation (AF)-related miRNAs on ion channels.

methods112 patients with AF were assigned into observation group, and another 112 non-AF people were assigned into control group. Total plasma RNAs were extracted from patients' blood samples. Differentially expressed miRNA-1s were transfected into primary-cultured neonatal rat cardiac myocytes.

resultsCompared with control group, significant differences were observed in 15 kinds of miRNAs in observation group. Down-regulation of the expression of miRNAs included hsa-miR-328, hsa-miR-145, hsa-miR-222, hsa-miR-1, hsa-miR-162, hsa-miR-432, and hsa-miR-493b; Up-regulation of the expression included hsa-miR634, hsa-miR-664, hsa-miR-9, hsa-miR-152, hsa-miR-19, hsa-miR-454, hsa-miR-146, and hsa-miR-374a. The expression level of CACNB2 protein in miRNA-1 group was significantly lower than that in blank control group, negative control group, MTmiRNA-1 group, AMO-1 group and miRNA-1+AMO-1 cotransfection group (P < 0.05), while in AMO-1 group, the expression level of CACNB2 protein was significantly higher than that in other groups (P < 0.05). These results indicated that transfected miRNA-1 could significantly inhibit the expression of CACNB2 protein.

conclusionsCirculating miRNAs can be used in studies concerning on the regulation mechanism of the occurrence and development of AF. MiRNA-1 can decrease the intracellular Ca(2+) concentration and prevent the AF.

Indexed as

Atrial fibrillationcardiac myocyteexpression profile of geneL-type Ca2+ channelmiRNAs

Identifiers

PMID25785065
PMCPMC4358520
OpenAlexW13834073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.